Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming III

ABSTRACT: Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming III

PROVIDER: PRJNA1111938 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR29044370_1.fastq.gz	Fastqsanger.gz
	SRR29044370_2.fastq.gz	Fastqsanger.gz
	SRR29044371_1.fastq.gz	Fastqsanger.gz
	SRR29044371_2.fastq.gz	Fastqsanger.gz
	SRR29044372_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 48

Similar Datasets

Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming

Project description:Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming

| PRJNA1063270 | ENA

Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming III

Project description:Late-onset Alzheimer’s disease (LOAD) is the most common form of AD. However, modeling sporadic LOAD, without clear genetic predispositions, to capture hallmark neuronal pathologies such as extracellular amyloid-β (Aβ) plaque deposition, intracellular tau tangles, and neuronal loss, remains an unmet need. Here, we demonstrate that neurons generated by microRNA-based direct reprogramming of fibroblasts from patients affected by autosomal dominant AD (ADAD) and LOAD in a three-dimensional (3D) environment, effectively recapitulate key neuropathological features of AD without additional cellular or genetic insults. These LOAD neurons exhibit Aβ-dependent neurodegeneration, as treatment with β- or γ-secretase inhibitors before (but not subsequent to) Aβ deposit formation mitigated neuronal death. Moreover, inhibiting age-associated retrotransposable elements (RTEs) in LOAD neurons reduced both Ab deposition and neurodegeneration. Our study underscores the efficacy of modeling late-onset neuropathology of LOAD through high-efficiency microRNA-based neuronal reprogramming.

2024-08-05 | GSE267613 | GEO

Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming II

Project description:Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming II

| PRJNA1064158 | ENA

Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming

2024-08-05 | GSE252932 | GEO

Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming II

2024-08-05 | GSE253174 | GEO

Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming.

Project description:Late-onset Alzheimer's disease (LOAD) is the most common form of Alzheimer's disease (AD). However, modeling sporadic LOAD that endogenously captures hallmark neuronal pathologies such as amyloid-β (Aβ) deposition, tau tangles, and neuronal loss remains an unmet need. We demonstrate that neurons generated by microRNA (miRNA)-based direct reprogramming of fibroblasts from individuals affected by autosomal dominant AD (ADAD) and LOAD in a three-dimensional environment effectively recapitulate key neuropathological features of AD. Reprogrammed LOAD neurons exhibit Aβ-dependent neurodegeneration, and treatment with β- or γ-secretase inhibitors before (but not subsequent to) Aβ deposit formation mitigated neuronal death. Moreover inhibiting age-associated retrotransposable elements in LOAD neurons reduced both Aβ deposition and neurodegeneration. Our study underscores the efficacy of modeling late-onset neuropathology of LOAD through high-efficiency miRNA-based neuronal reprogramming.

| S-EPMC11787906 | biostudies-literature

Genetic Consortium for Late Onset Alzheimer's Disease 6K

Project description:Genetic Consortium for Late Onset Alzheimer's Disease 6K

| PRJNA75441 | ENA

Cell-type specific profiling of human entorhinal cortex at the onset of Alzheimer’s disease neuropathology [scRNA-seq]

Project description:Neurons located in the layer II of the entorhinal cortex (ECII) are the primary site of pathological tau accumulation and neurodegeneration at preclinical stages of Alzheimer's disease (AD). Exploring the alterations that underlie the early degeneration of these cells is essential to develop therapies that delay disease onset. Here we performed cell–type specific profiling of the EC at the onset of human AD neuropathology. We identify an early response to amyloid pathology by microglia and oligodendrocytes. More importantly, we find that the Reelin signaling pathway is already impaired at this early disease stage, particularly in ECII neurons. This indicates that dysregulation of this pathway, with emerging genetic association with AD, plays a pivotal role in the selective vulnerability of the EC and in the onset of AD neuropathology.

2025-01-22 | GSE287652 | GEO

Cell-type specific profiling of human entorhinal cortex at the onset of Alzheimer’s disease neuropathology [RNA-seq]

2025-01-22 | GSE287651 | GEO

CIDR_NIA Late Onset Alzheimer's Disease:Genome-Wide Association Study

Project description:CIDR_NIA Late Onset Alzheimer's Disease:Genome-Wide Association Study

| PRJNA75485 | ENA